Thanks for the memory clinicFamily doctor finds a better way to treat dementia patients in primary care The ‘real’ Alzheimer’s gene steps forwardPrevention trial enrolls patients identified as high-risk for late-onset disease by genetic testing Vimpat: new antiepileptic for partial seizures UCB Canada is introducing Vimpat as adjunctive therapy in the management of epilepsy. Peoples’ jobs linked to area of brain degeneration For physicians with a patient presenting with signs of dementia, the person’s career path may provide clues about their brain health. ‘Destination amnesia’ could impair patient encounters Facing autism A focus on diagnosis, current controversies and proven treatments. First oral MS drug approved in U.S. Fingolimod (Gilenya, Novartis) offers patients an alternative to injectable therapies. Two Canadian centres win stroke care honours Calgary, Toronto Rehab earn new accreditation Stroke costs in Canada found to be double previous estimates Price-tag for first six months after ischemic stroke: close to $50,000 Daughters more prone to depression than sons when caring for parent with stroke Supports needed for family members who are “critical” to stroke recovery: MD First Previous 40 41 42 43 44 Next Last
